Evidence map›Paper›PMID 34757515›Full record

ArticleInternational journal of clinical pharmacy2022

The CombiConsultation: a new concept of sequential consultation with the pharmacist and practice nurse/general practitioner for patients with a chronic condition.

Valérie A M Meijvis, Mette Heringa, Henk-Frans Kwint, Niek J de Wit, Marcel L Bouvy

Abstract read
In one paragraph

Article in International journal of clinical pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Valérie A M MeijvisSIR Institute for Pharmacy Practice and Policy, 2331 JE, Leiden, The Netherlands. v.meijvis@sirstevenshof.nl.ORCID http://orcid.org/0000-0002-9528-5920
Mette HeringaSIR Institute for Pharmacy Practice and Policy, 2331 JE, Leiden, The Netherlands.
Henk-Frans KwintSIR Institute for Pharmacy Practice and Policy, 2331 JE, Leiden, The Netherlands.
Niek J de WitDepartment of General Practice, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands.
Marcel L BouvyDepartment of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

Funding

ZonMw 848023004
6 · The paper itself

Abstract

The primary health care system is generally well organized for dealing with chronic diseases, but comprehensive medication management is still a challenge. Studies suggest that pharmacists can contribute to effective and safe drug therapy by providing services like a clinical medication review (CMR). However, several factors limit the potential impact of a CMR. Therefore, we propose a new pharmaceutical care service for patients with a chronic condition: the CombiConsultation. The CombiConsultation is a medication evaluation service conducted by the (community) pharmacist and either the practice nurse or general practitioner. It consists of 3 steps: medication check, implementation and follow-up. The pharmacist primarily focusses on setting treatment goals for 1 or 2 drug-related problems in relation to a specific chronic condition. In this manuscript we describe the process and characteristics of the CombiConsultation. We compare the CombiConsultation with the CMR and explain the choices made and the implications for implementation.

Indexed as

General PractitionersPharmaceutical ServicesChronic DiseaseHumansMedication Therapy ManagementPharmacistsReferral and ConsultationCombiConsultationCommunity pharmacistGeneral practitionerPharmaceutical carePractice nursePrimary care

Identifiers

PMID34757515
PMCPMC9007762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.